Literature DB >> 28600865

Immune deficiency and autoimmunity in patients with CTLA-4 (CD152) mutations.

N Verma1, S O Burns1,2, L S K Walker2, D M Sansom2.   

Abstract

Immune deficiency disorders are a heterogeneous group of diseases of variable genetic aetiology. While the hallmark of immunodeficiency is susceptibility to infection, it is increasingly clear that autoimmunity is prevalent, suggestive of a more general immune dysregulation in some cases. With the increasing use of genetic technologies, the underlying causes of immune dysregulation are beginning to emerge. Here we provide a review of the heterozygous mutations found in the immune checkpoint protein CTLA-4, identified in cases of common variable immunodeficiency disorders (CVID) with accompanying autoimmunity. Study of these mutations provides insights into the biology of CTLA-4 as well as suggesting approaches for rational treatment of these patients.
© 2017 British Society for Immunology.

Entities:  

Keywords:  T cells; autoimmunity; co-stimulation; immunodeficiency diseases; regulatory T cells

Mesh:

Substances:

Year:  2017        PMID: 28600865      PMCID: PMC5588810          DOI: 10.1111/cei.12997

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  50 in total

1.  Dendritic cell-restricted CD80/86 deficiency results in peripheral regulatory T-cell reduction but is not associated with lymphocyte hyperactivation.

Authors:  Liat Bar-On; Tal Birnberg; Ki-wook Kim; Steffen Jung
Journal:  Eur J Immunol       Date:  2011-01-11       Impact factor: 5.532

Review 2.  Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family.

Authors:  Hélène Bour-Jordan; Jonathan H Esensten; Marc Martinez-Llordella; Cristina Penaranda; Melanie Stumpf; Jeffrey A Bluestone
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

3.  Assessment of CTLA-4 Deficiency-Related Autoimmune Choroidopathy Response to Abatacept.

Authors:  Carol L Shields; Emil A T Say; Arman Mashayekhi; Sunir J Garg; James P Dunn; Jerry A Shields
Journal:  JAMA Ophthalmol       Date:  2016-07-01       Impact factor: 7.389

4.  Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous.

Authors:  M F Bachmann; G Köhler; B Ecabert; T W Mak; M Kopf
Journal:  J Immunol       Date:  1999-08-01       Impact factor: 5.422

5.  An obligate cell-intrinsic function for CD28 in Tregs.

Authors:  Ruan Zhang; Alexandria Huynh; Gregory Whitcher; Jihoon Chang; Jonathan S Maltzman; Laurence A Turka
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

6.  Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.

Authors:  P Waterhouse; J M Penninger; E Timms; A Wakeham; A Shahinian; K P Lee; C B Thompson; H Griesser; T W Mak
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728

7.  Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation.

Authors:  S Read; V Malmström; F Powrie
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

Review 8.  CD28 and CTLA-4 coreceptor expression and signal transduction.

Authors:  Christopher E Rudd; Alison Taylor; Helga Schneider
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

Review 9.  Why must T cells be cross-reactive?

Authors:  Andrew K Sewell
Journal:  Nat Rev Immunol       Date:  2012-09       Impact factor: 53.106

10.  CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms.

Authors:  Wataru Ise; Masako Kohyama; Katherine M Nutsch; Hyang Mi Lee; Anish Suri; Emil R Unanue; Theresa L Murphy; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2009-12-27       Impact factor: 25.606

View more
  31 in total

Review 1.  Checkpoint Inhibitors: Applications for Autoimmunity.

Authors:  Anna S Tocheva; Adam Mor
Journal:  Curr Allergy Asthma Rep       Date:  2017-09-27       Impact factor: 4.806

Review 2.  Allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency.

Authors:  Emma C Morris
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

3.  Association and gene-gene interaction analyses for polymorphic variants in CTLA-4 and FOXP3 genes: role in susceptibility to autoimmune thyroid disease.

Authors:  Nusrath Fathima; Parimala Narne; Mohammed Ishaq
Journal:  Endocrine       Date:  2019-02-15       Impact factor: 3.633

Review 4.  Tipping the balance: inhibitory checkpoints in intestinal homeostasis.

Authors:  Maria E Joosse; Iris Nederlof; Lucy S K Walker; Janneke N Samsom
Journal:  Mucosal Immunol       Date:  2018-11-29       Impact factor: 7.313

Review 5.  Novel human immunomodulatory T cell receptors and their double-edged potential in autoimmunity, cardiovascular disease and cancer.

Authors:  Pilar Martín; Rafael Blanco-Domínguez; Raquel Sánchez-Díaz
Journal:  Cell Mol Immunol       Date:  2020-11-24       Impact factor: 11.530

6.  Tumor Mutational Burden, Toxicity, and Response of Immune Checkpoint Inhibitors Targeting PD(L)1, CTLA-4, and Combination: A Meta-regression Analysis.

Authors:  Arsen Osipov; Su Jin Lim; Aleksandra Popovic; Nilofer S Azad; Daniel A Laheru; Lei Zheng; Elizabeth M Jaffee; Hao Wang; Mark Yarchoan
Journal:  Clin Cancer Res       Date:  2020-06-25       Impact factor: 12.531

7.  Impact of cytotoxic T-lymphocyte-associated protein 4 codon 17 variant and expression on vitiligo risk.

Authors:  Nawal S Gouda; Manal S Fawzy; Eman A Toraih
Journal:  J Clin Lab Anal       Date:  2021-05-01       Impact factor: 2.352

Review 8.  State-of-the-art diagnostic evaluation of common variable immunodeficiency.

Authors:  Theodore K Lee; Jessica D Gereige; Paul J Maglione
Journal:  Ann Allergy Asthma Immunol       Date:  2021-03-11       Impact factor: 6.248

Review 9.  Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC).

Authors:  Li-Chung Chiu; Shu-Min Lin; Yu-Lun Lo; Scott Chih-Hsi Kuo; Cheng-Ta Yang; Ping-Chih Hsu
Journal:  Vaccines (Basel)       Date:  2021-06-23

Review 10.  Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge.

Authors:  Giorgio Costagliola; Rita Consolini
Journal:  Clin Exp Immunol       Date:  2021-06-20       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.